Please login to the form below

Not currently logged in
Email:
Password:

St Ives buys Hive

Says healthcare consultancy complements the company’s existing offering
st ives group logo

The marketing and publishing firm St Ives Group has bought The Hive Group as part of its strategy to create a complementary range of marketing and communications services.

Post-acquisition, the central London-based Hive Group will operate as a subsidiary of St Ives. It will continue to be run by its existing management team, including founding directors Ian Busby, Jas Hummel and Tim Scorer.  There will be no change to staff numbers, St Ives told PMLiVE.

Set up in 2008, The Hive Group today has more than 75 employees. It provides strategic consulting and communications services to an international client base, including six of the top 10 pharmaceutical companies.

The group operates across three main divisions: Hive, its strategic healthcare consultancy and communications business, Pollen, a strategic medical communications consultancy, and eBee, a specialist digital healthcare agency.

The St Ives Group chairman, Patrick Martell, said that he was delighted to welcome the Hive team to the group, adding that Hive's blend of consultancy services and digital services would complement St Ives' existing marketing services businesses.

Hive's Busby, Hummel and Scorer described the acquisition as 'a testament to the talent of our whole team and the uniqueness of our business'.

The acquisition followed a six month long global process which saw The Hive Group look at a number of potential buyers, from private equity to big global partner, to find one that was right for the brand and the business, both now and in the future.

Article by
Tara Craig

9th May 2014

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Accession

Accession was a born from a passion and a vision. A passion to harness the power of market access to...

Latest intelligence

Personalised medicine: driving a need for greater diversity in clinical trials
Kate Shaw, Innovative Trials' Founder & CEO, investigates one of the biggest challenges facing clinical research today....
Congresses and conferences
Superstar congresses and conferences will stay centre stage but now share the limelight with virtual and hybrid events
With the pandemic having dimmed the lights on pharma conferences, their virtual and hybrid replacements have grasped the opportunity and are here to stay...
Cervical Cancer Prevention Month
In this first 2022 blog, the Innovative Trials' Equality & Diversity committee will be looking at raising awareness around Cervical Cancer...